All patients treated with TG4050 in the Phase I part of the trial remained disease-free after a minimum of two years of follow-up, confirming clinical proof of principle. Translational data showed ...

Specialists urge general physicians to probe self-medication history; prioritise early testing for dengue, malaria, chikungunya, and COVID ...

Phase I part showed 100% Disease-Free Survival (DFS) after a minimum of 2-year follow-up - providing clinical proof of principle for TG4050 Randomization of all patients expected to be completed by en ...

Discover how strong US fiscal flows and potential tax cuts in 2025 could boost market liquidity, SPX growth, and risk assets ...

Analysis of the features and strategies of the popular Indian gambling game 1Win Aviator: minimum deposits, current bonuses, life hacks for attracting maximum odds.

Customer returns don’t have to be the Achillies’ heel of retail balance sheets and supply chains. With the right strategy and ...

Year Treasury Bull 3X Shares may not be an attractive bet amid rising geopolitical risks, oil price impacts, and inflation ...

Hornetsecurity's new 365 Total Protection Plan 4 uses AI to upskill users and reduce the strain on IT personnel; New tool to ...

Dr. James McCaffrey from Microsoft Research presents a complete end-to-end demonstration of computing a matrix inverse using ...

The cyber weather is always bad, much worse than Ottawa,” said Yarker, Commander of the Canadian Armed Forces Cyber Command.

John Stewart of Pelsis Group reveals how digitalising pest control enables faster, more precise interventions for food and ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety update regarding ELEVIDYS ...